These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
328 related articles for article (PubMed ID: 12518274)
1. Initial triple therapy of acute mania, adding lithium and valproate to neuroleptics. Reischies FM; Hartikainen J; Berghöfer AM Pharmacopsychiatry; 2002 Nov; 35(6):244-6. PubMed ID: 12518274 [TBL] [Abstract][Full Text] [Related]
2. Efficacy of valproate versus lithium in mania or mixed mania: a randomized, open 12-week trial. Bowden CL; Mosolov S; Hranov L; Chen E; Habil H; Kongsakon R; Manfredi R; Lin HN Int Clin Psychopharmacol; 2010 Mar; 25(2):60-7. PubMed ID: 20101186 [TBL] [Abstract][Full Text] [Related]
3. A 12-week, open, randomized trial comparing sodium valproate to lithium in patients with bipolar I disorder suffering from a manic episode. Bowden C; Göğüş A; Grunze H; Häggström L; Rybakowski J; Vieta E Int Clin Psychopharmacol; 2008 Sep; 23(5):254-62. PubMed ID: 18703934 [TBL] [Abstract][Full Text] [Related]
4. Rates of remission/euthymia with quetiapine in combination with lithium/divalproex for the treatment of acute mania. Sussman N; Mullen J; Paulsson B; Vågerö M J Affect Disord; 2007; 100 Suppl 1():S55-63. PubMed ID: 17383736 [TBL] [Abstract][Full Text] [Related]
5. Initial lithium and valproate combination therapy in acute mania. Reischies FM; Hartikainen J; Berghöfer A Neuropsychobiology; 2002; 46 Suppl 1():22-7. PubMed ID: 12571429 [TBL] [Abstract][Full Text] [Related]
6. Quetiapine in the treatment of acute bipolar mania: efficacy across a broad range of symptoms. McIntyre RS; Konarski JZ; Jones M; Paulsson B J Affect Disord; 2007; 100 Suppl 1():S5-14. PubMed ID: 17391773 [TBL] [Abstract][Full Text] [Related]
7. [Valproate in the treatment of bipolar disorder]. Rzewuska M Psychiatr Pol; 2002; 36(2):239-57. PubMed ID: 12043042 [TBL] [Abstract][Full Text] [Related]
8. One-year rehospitalization rates of patients with first-episode bipolar mania receiving lithium or valproate and adjunctive atypical antipsychotics. Woo YS; Bahk WM; Jung YE; Jeong JH; Lee HB; Won SH; Lee KH; Jon DI; Yoon BH; Kim MD; Min KJ Psychiatry Clin Neurosci; 2014 Jun; 68(6):418-24. PubMed ID: 24506520 [TBL] [Abstract][Full Text] [Related]
9. The relationship between antimanic agent for treatment of classic or dysphoric mania and length of hospital stay. Frye MA; Altshuler LL; Szuba MP; Finch NN; Mintz J J Clin Psychiatry; 1996 Jan; 57(1):17-21. PubMed ID: 8543542 [TBL] [Abstract][Full Text] [Related]
10. Paliperidone extended-release as adjunctive therapy to lithium or valproate in the treatment of acute mania: a randomized, placebo-controlled study. Berwaerts J; Lane R; Nuamah IF; Lim P; Remmerie B; Hough DW J Affect Disord; 2011 Mar; 129(1-3):252-60. PubMed ID: 20947174 [TBL] [Abstract][Full Text] [Related]
11. A double blind, randomized, placebo-controlled trial of quetiapine as an add-on therapy to lithium or divalproex for the treatment of bipolar mania. Yatham LN; Vieta E; Young AH; Möller HJ; Paulsson B; Vågerö M Int Clin Psychopharmacol; 2007 Jul; 22(4):212-20. PubMed ID: 17519644 [TBL] [Abstract][Full Text] [Related]
12. Estimation of resource utilisation difference between lithium and valproate treatment groups from the VALID study. Li SC; Aggarwal SK J Med Econ; 2011; 14(3):350-6. PubMed ID: 21542675 [TBL] [Abstract][Full Text] [Related]
13. Health-economic implications of the onset of action of antimanic agents. Keck PE; McElroy SL; Bennett JA J Clin Psychiatry; 1996; 57 Suppl 13():13-8; discussion 19-22. PubMed ID: 8970501 [TBL] [Abstract][Full Text] [Related]
14. Comparison between lithium and valproate in the treatment of acute mania. Shafti SS; Shahveisi B J Clin Psychopharmacol; 2008 Dec; 28(6):718-20. PubMed ID: 19011453 [No Abstract] [Full Text] [Related]
15. Efficacy of sodium valproate and haloperidol in the management of acute mania: a randomized open-label comparative study. Sekhar S; Kalra B; Mendhekar DN; Tekur U J Clin Pharmacol; 2010 Jun; 50(6):688-92. PubMed ID: 20075184 [TBL] [Abstract][Full Text] [Related]
16. Effectiveness and medical costs of divalproex versus lithium in the treatment of bipolar disorder: results of a naturalistic clinical trial. Revicki DA; Hirschfeld RM; Ahearn EP; Weisler RH; Palmer C; Keck PE J Affect Disord; 2005 Jun; 86(2-3):183-93. PubMed ID: 15935238 [TBL] [Abstract][Full Text] [Related]
17. Allopurinol as an adjunct to lithium and haloperidol for treatment of patients with acute mania: a double-blind, randomized, placebo-controlled trial. Akhondzadeh S; Milajerdi MR; Amini H; Tehrani-Doost M Bipolar Disord; 2006 Oct; 8(5 Pt 1):485-9. PubMed ID: 17042886 [TBL] [Abstract][Full Text] [Related]
18. Neuroleptic exposure in bipolar outpatients in a research setting. Denicoff KD; Sollinger AB; Frye MA; Ali SO; Smith-Jackson EE; Leverich GS; Post RM Compr Psychiatry; 2000; 41(4):248-52. PubMed ID: 10929791 [TBL] [Abstract][Full Text] [Related]
19. Chronic treatment with both lithium and sodium valproate may normalize phosphoinositol cycle activity in bipolar patients. Silverstone PH; Wu RH; O'Donnell T; Ulrich M; Asghar SJ; Hanstock CC Hum Psychopharmacol; 2002 Oct; 17(7):321-7. PubMed ID: 12415549 [TBL] [Abstract][Full Text] [Related]
20. [Has drug treatment of manic disorders changed in clinical routine practice? Retrospective analysis of treatment modalities and results in a university psychiatric clinic]. Reetz-Kokott U; Müller-Oerlinghausen B Nervenarzt; 1996 Mar; 67(3):229-34. PubMed ID: 8901281 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]